Founding Partner
Boston Scientific has issued an urgent medical device correction for multiple ACCOLADE family pacemakers and cardiac resynchronization therapy pacemakers (CRT-P devices). Federal regulators classified this action as the most serious type of recall because continued use without corrective action may lead to severe injury or death.
The correction affects a broad range of implantable cardiac devices used to regulate abnormal heart rhythms. These devices are critical for patients who rely on consistent pacing support to maintain safe heart function. Any malfunction involving battery performance, telemetry systems, or safety mode activation may create life-threatening consequences for individuals who depend on these devices every day.
According to federal safety information, Boston Scientific reported four deaths and more than 2,500 serious injuries connected to the issue as of March 18, 2026. These reports have raised significant concerns among patients, physicians, caregivers, and legal professionals regarding device reliability and long-term patient safety.
The correction centers on software and firmware problems involving the Brady SMR5 update and subsequent Brady SMR6 corrective software. Problems identified include unintended device behavior, telemetry disablement, inaccurate battery diagnostics, and Safety Mode activation risks. In certain situations, these issues may lead to device malfunction or premature replacement.
Patients who experienced injuries, emergency procedures, device failure, worsening heart conditions, or additional surgeries may have legal rights. Families affected by serious complications or death may also pursue legal claims involving defective medical devices.
The correction applies to numerous pacemakers and CRT-P devices within the ACCOLADE family and related product lines. These implantable cardiac devices are used to manage bradycardia and other heart rhythm disorders.
Affected product lines include:
These devices were implanted in patients throughout the United States and internationally. Many affected individuals may still have the devices implanted today.
Some affected models reportedly face increased risks involving reduced battery longevity and intensified follow-up recommendations. Certain patients may require more frequent monitoring due to concerns involving battery impedance and telemetry failure.
Because these devices are surgically implanted into the body, correcting the issue is far more complicated than recalling a standard consumer product. Patients often depend entirely on these devices for proper heart function, meaning any malfunction may create immediate medical emergencies.
Boston Scientific initiated the correction after identifying serious problems involving battery impedance and telemetry functionality. The company previously launched the Brady SMR5 software update to address earlier concerns involving Safety Mode activation. However, additional unintended behaviors reportedly emerged after the update was deployed.
According to federal safety information, identified issues include:
The company later implemented Brady SMR6 software in an attempt to correct the problems associated with Brady SMR5.
Pacemakers rely on precise software and battery management systems to maintain safe operation. If telemetry systems malfunction or batteries become unstable, the device may fail to communicate properly with monitoring systems or healthcare providers. In serious cases, the pacemaker may enter Safety Mode unexpectedly.
Safety Mode may significantly alter pacing behavior. For pacemaker-dependent patients, these changes may create dangerous cardiac complications.
The reported risks associated with the affected devices are serious and potentially life-threatening. Patients who rely on implanted pacemakers often require uninterrupted cardiac support. Device instability or battery problems may create substantial medical dangers.
Potential complications may include:
Some patients may face an increased risk if they are pacemaker-dependent and not monitored remotely via Boston Scientific’s LATITUDE system.
Federal regulators also warned about risks involving “wanded telemetry,” which may induce Safety Mode under certain conditions. This issue appears particularly concerning for patients with limited remaining battery longevity.
Even when patients do not immediately experience symptoms, device malfunctions may still create hidden dangers. Battery performance issues may worsen over time, potentially increasing the risk of sudden device failure.
As of March 18, 2026, Boston Scientific reported:
4 deaths
2,557 serious injuries
These numbers are significant for any implanted medical device correction. Serious injuries involving cardiac devices may include emergency interventions, surgical procedures, worsening cardiac symptoms, and life-threatening complications.
Some patients may require device replacement surgery earlier than anticipated due to battery concerns or telemetry disablement. Device replacement procedures carry their own risks, including:
Patients who underwent additional surgeries or emergency treatment may face physical, emotional, and financial burdens.
Modern pacemakers depend heavily on software and firmware systems to regulate pacing, monitor battery conditions, and communicate with healthcare providers. Software updates are often intended to improve safety and performance, but software errors may create new risks.
According to federal information, Brady SMR5 introduced unintended behaviors involving telemetry disablement and battery test interpretation. Boston Scientific later developed Brady SMR6 to correct those issues.
Firmware problems in implantable cardiac devices may create unique dangers because the devices operate continuously inside the body. Unlike consumer electronics, software failures in cardiac devices may directly affect life-sustaining functions.
Patients may not know a software problem exists until symptoms develop or a physician identifies abnormalities during device monitoring.
Patients harmed by defective pacemakers may have legal rights under product liability laws. Medical device manufacturers have a responsibility to design, manufacture, test, and monitor devices for safety.
Potential legal claims may involve:
Patients who suffered injuries may seek compensation for:
Families who lost loved ones may also pursue wrongful death claims.
Because these devices were implanted nationwide, affected individuals across the country may qualify to pursue legal action.
Patients with affected pacemakers should not panic or attempt to make medical decisions without guidance from their healthcare providers. However, patients should take the correction seriously and speak with their physicians regarding recommended follow-up care.
Important steps may include:
Patients experiencing dizziness, chest pain, fainting, shortness of breath, or unusual symptoms should seek immediate medical attention.
Possibly. Patients who experienced injuries, complications, additional surgeries, or worsening medical conditions related to the affected devices may qualify to pursue legal claims.
Emergency surgery related to device failure or battery problems may support a legal claim. Medical records and physician documentation may help establish the connection.
In some situations, surviving family members may pursue wrongful death claims if a loved one died due to complications involving an affected pacemaker.
Compensation may include medical expenses, lost wages, pain and suffering, future medical care, and damages associated with additional surgeries or complications.
Patients may check model numbers with their healthcare providers or use Boston Scientific’s device lookup system. Medical providers can also confirm whether firmware updates were performed.
Patients should speak directly with their physicians. In many cases, physicians may recommend monitoring and software updates rather than immediate replacement.
Safety Mode is a protective operating state intended to maintain limited device function during certain malfunctions. However, unexpected Safety Mode activation may create serious risks for some patients.
Deadlines vary depending on state law and the circumstances of the injury. Prompt legal review may help preserve important rights.
Patients who suffered complications involving Boston Scientific ACCOLADE pacemakers or CRT-P devices may have legal options. If you or a loved one experienced device malfunction, emergency surgery, worsening cardiac symptoms, or other serious complications, Parker Waichman LLP is investigating claims nationwide.
Parker Waichman LLP offers free consultations for individuals affected by defective medical devices. Learn whether you may qualify to pursue compensation for medical expenses, pain and suffering, and related losses.
Call Parker Waichman LLP today at 1-800-YOUR-LAWYER (1-800-968-7529) for a free consultation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
We handle mass torts cases nationwide. Please contact our office to learn more.